Sorry, you need to enable JavaScript to visit this website.

    Pfizer Invites Public to Listen to Webcast of April 20 Conference Call with Analysts

    (BUSINESS WIRE)--Pfizer Inc invites investors and the general public to listen to a webcast of a conference call with investment analysts at 12 Noon EDST on Friday, April 20. The purpose of the call is to provide an update on Pfizers results, as reflected in the companys First Quarter 2007 Performance Report, to be issued that morning.

    To listen to the webcast and view the Performance Report, visit our web site homepage at www.pfizer.com and click on the Quarterly Corporate Performance First Quarter 2007 link. Information on accessing, and pre-registering for, the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.

    Visitors to www.pfizer.com will be able to listen to an archived copy of the webcast of the conference call through 12 Noon, Friday, April 27.

    Pfizer Inc
    Shreya Prudlo, 212/733-4889

    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now